Vinorelbine Tartrate for Injection
Function and Efficacy
This product is a broad-spectrum anti-tumor drug and a semi-synthetic derivative of vinblastine. It mainly stops cell division at the metaphase of mitosis by inhibiting the polymerization of centromere microtubules. It is a cell cycle-specific drug.
Ingredients
The main ingredient of this product is vinorelbine tartrate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Vinorelbine tartrateIngredients |
This product is a broad-spectrum anti-tumor drug and a semi-synthetic derivative of vinblastine. It mainly stops cell division at the metaphase of mitosis by inhibiting the polymerization of centromere microtubules. It is a cell cycle-specific drug. More |
125317-39-7 | 20 |
Appearance
White loose lumps or powder.
Indication
This product is suitable for patients with non-small cell lung cancer and breast cancer.
Usage and Dosage
This product can only be administered intravenously. Single-drug chemotherapy: The recommended dose is based on body surface area: 25-30 mg/m2, and it is dissolved in normal saline before use. Combined chemotherapy: The dose and administration time are selected according to the scheme used. Generally, it is based on body surface area: 25-30 mg/m2. The drug must be dissolved in normal saline and injected intravenously in a short time (15-20 minutes), and then the vein is flushed with normal saline.
Adverse Reactions
Not yet clear
Precautions
It is contraindicated for pregnant or lactating women and those with severe liver impairment.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
20mg (based on C45H54N4O8)